02/02/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/2/2020. This web page, updated on February 2, 2020, provides general and specific biosafety guidelines for handling 2019 novel coronavirus (2019-nCoV) specimens, as well as information about clinical laboratory testing; packing, shipping, and transport; and related resources. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible 2019-nCoV infection. (Text)
02/01/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/1/2020. This flowchart is to be used for the evaluation of patients who may be ill with or who may have been exposed to 2019 Novel Coronavirus (2019-nCoV). Steps include Identify, Isolate, Assess clinical status, Instruct patient, and Advise patient. (Text)
02/01/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 2/2020. This four-page document aims to provide guidance to European Union/European Economic Area (EU/EEA) healthcare facilities and healthcare providers on infection prevention and control measures during the management of suspected and confirmed cases of 2019-nCoV infection. It is for hospital administrators and healthcare practitioners in EU/EEA Member States. (PDF)
01/30/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 1/30/2020. This one-page leaflet is an adaptable template providing advice about the novel coronavirus to healthcare workers on handling and caring of patients with 2019-nCoV infection, including when to suspect a 2019-nCoV infection. (PDF)
01/30/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 1/30/2020. For surveillance at the European level, the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization Regional Office for Europe request countries to report probable and confirmed cases of 2019-nCoV infections using the global case definition within 24 hours after identification. This web page provides a detailed case definition for surveillance, with testing and laboratory guidance. (Text)
01/29/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention (CDC). Published: 1/29/2020. This 56-minute webinar from the Centers for Disease Control and Prevention (CDC)’s Emergency Partners Information Connection discusses how to plan and build partnerships in public health emergencies, how to make partnerships mutually beneficial, and how to work with partners to share information with those people who need it most. It discusses why communication partnerships are needed, demonstrates messaging through a social network, and describes defining audiences. (Video or Multimedia)
01/28/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/28/2020. As part of the World Health Organization’s response to the 2019 novel coronavirus (2019-nCoV) outbreak, the R&D Blueprint has been activated to accelerate diagnostics, vaccines, and therapeutics for this novel coronavirus. This web page provides links to the latest reports about vaccines, therapeutics, and diagnostics from the Scientific Advisory Group and Global Coordination Mechanism. (Text)
01/21/2020 12:00 AM EST
Source: National Library of Medicine [National Institutes of Health] (NLM). Published: 1/21/2020. In this one-hour, 14-minute presentation from the National Network of Libraries of Medicine, the National Association of County and City Health Officials (NACCHO) and healthcare coalition (HCC) representatives provide an overview of the strengths and challenges experienced by rural and frontier HCCs, and discuss how these groups work to make their communities more resilient. Participants will be able to describe how healthcare coalitions in rural and frontier areas can support and maintain preparedness, and explain lessons learned, best practices, and barriers to healthcare coalitions in rural and frontier areas. (Video or Multimedia)
01/01/2020 12:00 AM EST
Source: U.S. Government Accountability Office (GAO). Published: 1/2020. This 53-page report examines, among other things, how the Drug Enforcement Administration (DEA) obtains and uses industry-reported data to identify and address suspicious opioid orders, and opportunities for DEA to improve these efforts, such as using computer algorithms or real-time reporting. The study includes data and information on the prescription drug supply chain, identifies deficiencies associated with DEA’s drug diversion efforts, and makes four recommendations related to DEA’s collection and use of industry-reported data. (PDF)
12/12/2019 12:00 AM EST
Source: National Association of County and City Health Officials (NACCHO). Published: 12/12/2019. This one-hour webinar explores how to use One Health collaborations to enhance investigation capacity for One Health issues facing public health, such as vector-borne diseases and zoonoses driven by wildlife diversity, socioeconomic disparities, and extreme weather events. Speakers provide an overview of a comprehensive One Health Toolkit, which addresses the need to outline and document partner roles and responsibilities, and aims to strengthen existing collaborations, foster communication, and enhance capacity for routine investigations and emergency preparedness purposes; discuss how the toolkit helped with a plague investigation; and explore implications of this toolkit for other local health departments. (Video or Multimedia)
12/11/2019 12:00 AM EST
Source: Centers for Medicare and Medicaid Services (CMS). Published: 12/11/2019. This 44-minute Long-Term Services and Supports (LTSS) webinar looks at ways tribal communities can plan ahead to better position themselves to respond to emergencies and assist older adults, caregivers, and vulnerable community members during an emergency. Participants will learn about emergency preparedness planning, and identify related planning tools and resources. (Video or Multimedia)
12/01/2019 12:00 AM EST
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 12/2019. This report describes the five-year interagency budget plan for the basic research, advanced research and development, regulatory review, procurement, stockpiling, and replenishment of the U.S. government’s civilian medical countermeasure enterprise for Fiscal Years 2018-2022. It describes estimated spending by threat for the cumulative five-year period and the change relative to the last year’s report, including for pandemic and seasonal influenza; broad spectrum antimicrobials; filoviruses, including Ebola; and chemical, nuclear, and radiological threats. (Text)
07/01/2019 12:00 AM EDT
Source: Centers for Disease Control and Prevention, National Center for Environmental Health (CDC NCEH). Published: 7/2019. This course defines what is meant by a disaster, looks at the potential public health impacts of the disaster, and reviews how direct and indirect health effects differ. It discusses the role of a disaster epidemiologist, and provides a brief overview of the field of disaster epidemiology and response. (Video or Multimedia)
07/01/2019 12:00 AM EDT
Source: Centers for Disease Control and Prevention, National Center for Environmental Health (CDC NCEH). Published: 7/2019. The first module of the Disaster Mortality Online Training series reviews the public health impacts of disasters. In this 50-minute course, learners will review basic concepts about disasters; look at the direct and indirect impact of disasters on public health in different types of communities; and discuss how and why certain populations are disproportionately vulnerable to these impacts. (Video or Multimedia)
07/01/2019 12:00 AM EDT
Source: Centers for Disease Control and Prevention, National Center for Environmental Health (CDC NCEH). Published: 7/2019. The second module of the Disaster Mortality Online Training series reviews public health emergency management. This 45-minute course provides learners with a summary of public health emergency management and planning for a disaster response and recovery, the role and function of public health agencies in a disaster, and the implications of the relevant federal laws and authorities related to public health’s role in a disaster. (Video or Multimedia)
07/01/2019 12:00 AM EDT
Source: Centers for Disease Control and Prevention, National Center for Environmental Health (CDC NCEH). Published: 7/2019. The third module of the Disaster Mortality Online Training series is dedicated to the Community Assessment for Public Health Emergency Response (CASPER). In this 75-minute course, learners will review the CASPER methodology, when to conduct a CASPER, and how to implement a CASPER, including basic data analysis and interpretation. (Video or Multimedia)
07/01/2019 12:00 AM EDT
Source: Centers for Disease Control and Prevention, National Center for Environmental Health (CDC NCEH). Published: 7/2019. The fourth module of the Disaster Mortality Online Training series covers disaster morbidity and mortality surveillance. In this 40-minute course, learners will review why disaster surveillance is important, the purpose of morbidity and mortality surveillance during a response, and the tools to assist in disaster surveillance. (Video or Multimedia)
05/01/2019 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 5/2019. This 47-page document describes the five-year interagency budget plan for the basic research, advanced research and development, regulatory review and approval, procurement, stockpiling, and replenishment of the United States government’s civilian medical countermeasure enterprise for Fiscal Years 2017-2021. It provides an update of the Public Health Emergency Medical Countermeasures Enterprise budget priorities across chemical, biological, radiological, and nuclear (CBRN) threats; pandemic influenza; and other emerging, or re-emerging, infectious diseases. (PDF)
.png)
No hay comentarios:
Publicar un comentario